Company

PTC Therapeutics, Inc.

PTC Therapeutics develops treatments for rare diseases.

About

Founded in 1998, PTC Therapeutics is headquartered in South Plainfield, New Jersey. It develops therapies for rare diseases, including treatments for Duchenne muscular dystrophy and phenylketonuria. In 2024, the company reported USD 806.78 mn in revenue and USD -226.91 mn in EBITDA. It has completed 18 funding deals, including a USD 1,000 mn PIPE in February 2014 backed by Blackstone Group.

6Funding rounds

13Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in